StonvexLoading…
StonvexStonvexStonvexCore line items from ANVS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | Not available | $-18.01M | $-29.70M | $-19.99M | $-12.55M |
Net Income | Not available | $-17.61M | $-28.85M | $-19.02M | $-6.22M |
EPS (Diluted) | $-0.33 | $-0.63 | $-1.40 | $-1.01 | $-0.64 |
Total Assets | Not available | $16.24M | $21.08M | $17.19M | $21.45M |
Total Liabilities | Not available | $13.12M | $4.23M | $4.03M | $3.12M |
Cash & Equivalents | Not available | $14.22M | $19.53M | $15.29M | $17.13M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 28.54M | 27.20M | 20.19M | 19.49M |